छोड़कर सामग्री पर जाएँ

UBS downgrades Syngene to ‘sell’ on weak outlook, shares slip 3%

The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.

Read More

​ The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS. The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी